a public good project by the
Synthesis
Company
of California

© 2026

Maureen Sampson | doi.page

0 works0 citations0 h-index

Maureen Sampson

National Institutes of Health Clinical Center(US)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Cholesterol and Lipid Metabolism, Metabolomics and Mass Spectrometry Studies

Most-Cited Works

→ A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia(2020)526 cited
→ Metabolite Profiling of a NIST Standard Reference Material for Human Plasma (SRM 1950): GC-MS, LC-MS, NMR, and Clinical Laboratory Analyses, Libraries, and Web-Based Resources(2013)302 cited
→ Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer(2006)287 cited
→ The Differential Effect of Food Intake and β-Adrenergic Stimulation on Adipose-Derived Hormones and Cytokines in Man(1999)175 cited
→ Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients(2014)158 cited
→ A cholesterol-lowering VLP vaccine that targets PCSK9(2015)147 cited

→ Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism(1999)

136 cited

→ Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial(2015)93 cited

→ High Pre-β1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol(2010)90 cited

→ A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test(2021)89 cited